-
Signature
-
/s/ Sheryl Southwick, Attorney-in-fact
-
Stock symbol
-
TNET
-
Transactions as of
-
Aug 25, 2023
-
Transactions value $
-
-$1,336,820
-
Form type
-
4
-
Date filed
-
8/29/2023, 06:06 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
TNET |
Common Stock |
Options Exercise |
$318K |
+9.5K |
+5.56% |
$33.51 |
180K |
Aug 25, 2023 |
Direct |
F1, F2 |
transaction |
TNET |
Common Stock |
Sale |
-$1M |
-9.5K |
-5.27% |
$105.57 |
171K |
Aug 25, 2023 |
Direct |
F2, F3, F4 |
transaction |
TNET |
Common Stock |
Options Exercise |
$301K |
+8.97K |
+5.26% |
$33.51 |
180K |
Aug 28, 2023 |
Direct |
F1, F2 |
transaction |
TNET |
Common Stock |
Sale |
-$953K |
-8.97K |
-4.99% |
$106.24 |
171K |
Aug 28, 2023 |
Direct |
F2, F3, F5 |
holding |
TNET |
Common Stock |
|
|
|
|
|
410K |
Aug 25, 2023 |
By Trust |
F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
TNET |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-9.5K |
-16.45% |
$0.00 |
48.2K |
Aug 25, 2023 |
Common Stock |
9.5K |
$33.51 |
Direct |
F1, F7 |
transaction |
TNET |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-8.97K |
-18.61% |
$0.00 |
39.3K |
Aug 28, 2023 |
Common Stock |
8.97K |
$33.51 |
Direct |
F1, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: